Reshape Lifesciences Inc. buy melinda
Start price
20.04.21
/
50%
€350.25
Target price
20.04.22
€525.00
Performance (%)
-85.52%
End price
21.04.22
€50.73
Summary
This prediction ended on 21.04.22 with a price of €50.73. Massive losses of -85.52% were the result for the BUY prediction by melinda. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Reshape Lifesciences Inc. | - | - | - | - |
| iShares Core DAX® | 0.000% | -2.064% | 13.111% | 16.685% |
| iShares Nasdaq 100 | 0.626% | -2.884% | 37.744% | 43.441% |
| iShares Nikkei 225® | 1.568% | -5.892% | 19.592% | 4.617% |
| iShares S&P 500 | 0.334% | -2.281% | 27.745% | 41.046% |
According to melinda what are the pros and cons of Reshape Lifesciences Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Obalon Therapeutics Inc. diskutieren
In the thread Trading Obalon Therapeutics Inc.
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for Reshape Lifesciences Inc.
Reshape Lifesciences Inc.
Start price
Target price
Perf. (%)
€702.00
24.01.21
24.01.21
-
24.01.22
24.01.22
-50.11%
20.04.21
20.04.21
Could be worthwhile Investment >10% per year
